{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:26:07Z","timestamp":1778725567185,"version":"3.51.4"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Apart from pulmonary vein isolation (PVI), several step-by-step procedures that aim to modify left atrial substrate have been proposed for the ablation of persistent atrial fibrillation (AF), yet the optimal strategy remains elusive. There are cumulative data suggesting an incremental benefit of adding vein of Marshall (VOM) ethanol infusion to PVI in patients with persistent AF. We sought to evaluate the feasibility and efficacy of a novel stepwise ablation approach, incorporating a VOM alcoholization step, for persistent AF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this single-center study, we prospectively enrolled 66 consecutive patients with symptomatic persistent AF and failure of at least one antiarrhythmic drug (ADD). The ablation procedure consisted of (i) PVI, (ii) left atrial segmentation with VOM ethanol infusion and the deployment of linear radiofrequency lesions across the roof and the mitral isthmus and (iii) electrogram-based ablation of dispersion zones. The first two steps were performed in all patients, whereas the third step was carried out only in those still in AF at the end of the second step. Atrial tachycardias during the procedure were mapped and ablated. At the end of the procedure, cavotricuspid isthmus ablation was additionally performed in all patients. The primary endpoint was 12-month freedom from AF and atrial tachycardia after a single procedure and an initial three-month blanking period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Total procedure time was 153\u2009\u00b1\u200938.5\u2005min. Fluoroscopy time was 16\u2009\u00b1\u20096.5\u2005min and the radiofrequency ablation time was 26.14\u2009\u00b1\u20090.26\u2005min. The primary endpoint occurred in 54 patients (82%). At 12 months, 65% of patients were off any AAD. In the univariate Cox regression analysis, left ventricular ejection fraction &amp;lt;\u200940% was the only predictor of arrhythmia recurrence (HR 3.56; 95% CI, 1.04\u201312.19; <jats:italic>p<\/jats:italic>\u2009=\u20090.04). One patient developed a pericardial tamponade and another a minor groin hematoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A novel stepwise approach, including a step of ethanol infusion in the VOM, is feasible, safe and provides a high rate of sinus rhythm maintenance at 12 months in patients with persistent AF.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1194687","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T05:41:27Z","timestamp":1684215687000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel stepwise approach incorporating ethanol infusion in the vein of Marshall for the ablation of persistent atrial fibrillation"],"prefix":"10.3389","volume":"10","author":[{"given":"Vasileios","family":"Sousonis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Combes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Pinon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Combes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Cardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Zeriouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Men\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Paul","family":"Albenque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"B2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.hrthm.2015.10.023","article-title":"Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"B3","doi-asserted-by":"publisher","first-page":"f366","DOI":"10.1093\/europace\/eux297","article-title":"Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis","volume":"20","author":"Clarnette","year":"2018","journal-title":"Europace"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.jacc.2003.12.054","article-title":"A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate","volume":"43","author":"Nademanee","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jacc.2016.10.065","article-title":"AF ablation guided by spatiotemporal electrogram dispersion without pulmonary vein isolation: a wholly patient-tailored approach","volume":"69","author":"Seitz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s1043-0679(00)70011-6","article-title":"Current status of the maze procedure for the treatment of atrial fibrillation","volume":"12","author":"Cox","year":"2000","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/eurheartj\/ehl093","article-title":"Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison","volume":"27","author":"Willems","year":"2006","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/j.1540-8167.2005.00307.x","article-title":"Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination","volume":"16","author":"Ha\u00efssaguerre","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/CIRCEP.114.001672","article-title":"Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success","volume":"8","author":"Schreiber","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.hrthm.2011.04.012","article-title":"Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation","volume":"8","author":"Rostock","year":"2011","journal-title":"Heart Rhythm"},{"key":"B11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.hrthm.2010.02.028","article-title":"Electrophysiological characteristics of the Marshall bundle in humans","volume":"7","author":"Han","year":"2010","journal-title":"Heart Rhythm"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.hrthm.2019.05.019","article-title":"The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation","volume":"16","author":"Vlachos","year":"2019","journal-title":"Heart Rhythm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.hrthm.2009.07.036","article-title":"Ethanol infusion in the vein of Marshall: adjunctive effects during ablation of atrial fibrillation","volume":"6","author":"Valderr\u00e1bano","year":"2009","journal-title":"Heart Rhythm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.2020.16195","article-title":"Effect of catheter ablation with vein of marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial","volume":"324","author":"Valderr\u00e1bano","year":"2020","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1540-8167.2005.00308.x","article-title":"Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias","volume":"16","author":"Ha\u00efssaguerre","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e005114","DOI":"10.1161\/CIRCEP.117.005114","article-title":"Stand-alone pulmonary vein isolation versus pulmonary vein isolation with additional substrate modification as index ablation procedures in patients with persistent and long-standing persistent atrial fibrillation: the randomized alster-lost-AF trial (ablation at st. Georg hospital for long-standing persistent atrial fibrillation)","volume":"10","author":"Fink","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.jacc.2015.09.088","article-title":"Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial","volume":"66","author":"Vogler","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1111\/jce.14771","article-title":"Multiple procedure outcomes for nonparoxysmal atrial fibrillation: left atrial posterior wall isolation versus stepwise ablation","volume":"31","author":"Barbhaiya","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/jcdd9080270","article-title":"Ethanol infusion of vein of marshall for the treatment of persistent atrial fibrillation: the basics and clinical practice","volume":"9","author":"He","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e007273","DOI":"10.1161\/CIRCEP.119.007273","article-title":"Mechanism of recurrence of atrial tachycardia: comparison between first versus redo procedures in a high-resolution mapping system","volume":"13","author":"Takigawa","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jacep.2021.06.019","article-title":"Durability of left atrial lesions after ethanol infusion in the vein of Marshall","volume":"8","author":"Laredo","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.hrthm.2021.01.005","article-title":"Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: a secondary analysis of the VENUS randomized clinical trial","volume":"18","author":"Lador","year":"2021","journal-title":"Heart Rhythm"},{"key":"B24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10840-006-9045-1","article-title":"The stepwise ablation approach for chronic atrial fibrillation\u2013evidence for a cumulative effect","volume":"16","author":"O'Neill","year":"2006","journal-title":"J Interv Card Electrophysiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.hrthm.2020.12.023","article-title":"Marshall bundle elimination, pulmonary vein isolation, and line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): prospective, single-center study","volume":"18","author":"Derval","year":"2021","journal-title":"Heart Rhythm"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/jce.15108","article-title":"Effectiveness of ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the \u00ab upgraded 2C3l \u00bb approach) for catheter ablation of persistent atrial fibrillation","volume":"32","author":"Lai","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1540-8167.2012.02322.x","article-title":"Substrate modification by pulmonary vein isolation and left atrial linear ablation in patients with persistent atrial fibrillation: its impact on complex-fractionated atrial electrograms","volume":"23","author":"Matsuo","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"950763","DOI":"10.4061\/2010\/950763","article-title":"Atrial tachycardias arising from ablation of atrial fibrillation: a proarrhythmic bump or an antiarrhythmic turn?","volume":"2010","author":"Shah","year":"2010","journal-title":"Cardiol Res Pract"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/jce.13969","article-title":"Long-term efficacy and safety of adjunctive ethanol infusion into the vein of marshall during catheter ablation for nonparoxysmal atrial fibrillation","volume":"30","author":"Liu","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10840-022-01378-8","article-title":"The maine vein of Marshall ethanol experience: learning curve and safety","volume":"66","author":"Leyton-Mange","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e010001","DOI":"10.1161\/CIRCEP.121.010001","article-title":"Vein of Marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients","volume":"14","author":"Kamakura","year":"2021","journal-title":"Circ Arrhythm Electrophysiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1194687\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T10:19:28Z","timestamp":1685096368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1194687\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2023.1194687"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1194687","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"article-number":"1194687"}}